Prop-2-yn-1-yl-2-Amino-6-(2-(dimethylamino)pyridin-4-yl)-4-(2-oxo-2-(prop-2-yn-1-yloxy)ethyl)-4H-chromene-3-carboxylate

ID: ALA4173491

PubChem CID: 145949515

Max Phase: Preclinical

Molecular Formula: C25H23N3O5

Molecular Weight: 445.48

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C#CCOC(=O)CC1C(C(=O)OCC#C)=C(N)Oc2ccc(-c3ccnc(N(C)C)c3)cc21

Standard InChI:  InChI=1S/C25H23N3O5/c1-5-11-31-22(29)15-19-18-13-16(17-9-10-27-21(14-17)28(3)4)7-8-20(18)33-24(26)23(19)25(30)32-12-6-2/h1-2,7-10,13-14,19H,11-12,15,26H2,3-4H3

Standard InChI Key:  MBPADZLRXSZUQW-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 33 35  0  0  0  0  0  0  0  0999 V2000
   17.1317  -13.3081    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   17.1306  -14.1355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8453  -14.5483    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5618  -14.1350    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.5590  -13.3045    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   17.8436  -12.8954    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2770  -14.5464    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.2733  -15.3717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9876  -15.7830    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.9835  -14.1325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6984  -14.5402    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6995  -15.3663    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4115  -15.7761    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.1270  -15.3644    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1260  -14.5383    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4093  -14.1238    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8415  -15.7769    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.8402  -14.1255    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.5549  -14.5377    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.8400  -13.3005    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   24.2693  -14.1250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2690  -13.3000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.2686  -12.4750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.4071  -13.2988    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6915  -12.8883    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.6893  -12.0634    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   19.9782  -13.3028    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   21.4027  -11.6488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1182  -12.0594    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.8338  -12.4700    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4158  -14.5474    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   15.7017  -14.1343    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.4151  -15.3724    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  4  7  1  0
  7  8  2  0
  8  9  1  0
  9 12  2  0
 11 10  2  0
 10  7  1  0
 11 12  1  0
 11 16  1  0
 12 13  1  0
 13 14  1  0
 14 15  2  0
 15 16  1  0
 14 17  1  0
 15 18  1  0
 18 19  1  0
 18 20  2  0
 19 21  1  0
 21 22  1  0
 22 23  3  0
 16 24  1  0
 24 25  1  0
 25 26  1  0
 25 27  2  0
 26 28  1  0
 28 29  1  0
 29 30  3  0
  2 31  1  0
 31 32  1  0
 31 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4173491

    ---

Associated Targets(Human)

HL60/MX2 (68 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
HL-60 (67320 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.48Molecular Weight (Monoisotopic): 445.1638AlogP: 2.20#Rotatable Bonds: 7
Polar Surface Area: 103.98Molecular Species: NEUTRALHBA: 8HBD: 1
#RO5 Violations: HBA (Lipinski): 8HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 6.55CX LogP: 2.91CX LogD: 2.86
Aromatic Rings: 2Heavy Atoms: 33QED Weighted: 0.51Np Likeness Score: -0.60

References

1. Bian T, Chandagirikoppal Vijendra K, Wang Y, Meacham A, Hati S, Cogle CR, Sun H, Xing C..  (2018)  Exploring the Structure-Activity Relationship and Mechanism of a Chromene Scaffold (CXL Series) for Its Selective Antiproliferative Activity toward Multidrug-Resistant Cancer Cells.,  61  (15): [PMID:29995404] [10.1021/acs.jmedchem.8b00813]

Source